Registration Statement

Vanda Pharmaceuticals Inc. Filed 2026-02-12 Acc 0001628280-26-007476

Documents 1

2026-02-19 4 SVP, Chief Marketing Officer acquired 125,000 shares (grant or award)
2026-02-19 4 SVP, Business Development acquired 125,000 shares (grant or award)
2026-02-18 UPLOAD SEC-generated Letter
2026-02-12 S-3 Registration Statement
2026-02-12 10-K Annual Report
2026-02-11 8-K Results of operations
2023-02-09 S-3 Registration Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading vnda-20260212sx3.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…